Healing Trauma with MDMA: A Pathway to Recovery

Post-traumatic stress disorder, also known as PTSD, is a neuropsychiatric condition. Each year, roughly <a href="https://www.ptsd.va.gov/understand/common/common_adults.asp" rel="noopener ugc nofollow" target="_blank">5% of the US population</a> is affected by the disorder. The gold standard treatment, trauma-focused <a href="https://pubmed.ncbi.nlm.nih.gov/32063234/" rel="noopener ugc nofollow" target="_blank">psychotherapy</a>, does not yield desirable results as patients have persistent symptomology as well as <a href="https://pubmed.ncbi.nlm.nih.gov/32284816/" rel="noopener ugc nofollow" target="_blank">high drop-out rates</a>. Moreover, the FDA has approved several selective serotonin reuptake inhibitors, a.k.a. <a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3278188/" rel="noopener ugc nofollow" target="_blank">SSRIs</a>, for the treatment of PTSD. Unfortunately, 35–47% of patients don’t respond to these medications. Therefore, a new form of psychotherapy is necessary. <a href="https://medium.com/illumination/healing-trauma-with-mdma-a-pathway-to-recovery-cbe9342842d6">Read More</a>